Analyst Moves: ABBV, CMG, AAPL, DDD - Presented by: The Aol. On Network

This morning, Goldman Sachs added Abbvie (ABBV) to its Conviction Buy List noting that the company has an attractive pipeline of products. In the report, Goldman set a $60 price target.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
CPWR $ 10.59 1.24 ▲ 13.26%
BAC $ 16.27 0.18 ▲ 1.12%
AAPL $ 103.30 0.80 ▲ 0.78%
PBR $ 20.65 1.08 ▲ 5.52%
SPLS $ 12.63 0.95 ▲ 8.13%
FB $ 76.68 1.86 ▲ 2.49%
INTC $ 34.57 0.35 ▼ 1.00%
SIRI $ 3.64 0.01 ▲ 0.28%

As of 9/2/2014, 04:15 PM
More Most Active